Compare Motorola Solutions Inc (MSI) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Motorola Solutions Inc vs Novavax Inc — how do they compare? Motorola Solutions Inc trades at $405.33 (market cap $68.13B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: Motorola Solutions Inc is far larger — about 52.4× Novavax Inc's market cap, and Motorola Solutions Inc pays a 1.18% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| MSI | NVAX | |
|---|---|---|
Market Cap | $68.13B | $1.30B |
Sector | Technology | Health |
52-Week High | $490.30 | $11.19 |
52-Week Low | $363.83 | $6.22 |
Enterprise Value | $76.83B | $800.50M |
Dividend Yield | 1.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $406.28, down 1.7% on the day, with a bearish technical signal. The company reported strong earnings beats in recent quarters and maintains robust profitability with a 17.61% net margin and 99.88% ROE. Recent developments include the $1.5 billion acquisition of D-Fend Solutions and expansion of AI capabilities for emergency response systems, signaling strategic growth in public safety technology.
The outlook remains positive with a consensus price target of $512.33, implying 26% upside, supported by 71% analyst buy ratings. Risks include elevated valuation multiples (P/E 33.1) and significant investing cash outflows for acquisitions. The stock's near-term performance will hinge on execution of growth initiatives and Q2 2026 earnings relative to the $3.86 EPS estimate.
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
